Dr Malcolm Gillies[/caption]
PSA SA/NT Pharmacist of the Year Natasha Downing MPS[/caption]
PSA SA/NT ECP of the Year Raymond Truong MPS[/caption]
PSA SA/NT Intern of the YearChloe Hall MPS[/caption]
PSA SA/NT Lifetime Achievment Award recipient Peter Halstead FPS[/caption]
Pharmaceutical Society Gold Medal recipient Amelia Thompson[/caption]
Prof Danchin is a consultant paediatrician at the Royal Children’s Hospital and Clinician Scientist, University of Melbourne.
Overview of the categories 
Category B3
Patient considerations
Professor Lisa Nissen FPS[/caption]
Dr Jean Spinks[/caption]
Case scenario
Mrs Jones, aged 59, is a regular patient at your pharmacy. For the last few weeks she has come in almost daily to purchase various over the counter gastrointestinal products to relieve lower abdominal pain and bloating, along with nausea and dyspepsia. Today she comes in to ask you for something stronger, as she is not getting any relief from the products she has tried and her discomfort is severe. She also requests some Hiprex tablets, because she frequently feels the need to urinate. As you know Mrs Jones quite well, you can see she has lost weight in the last few weeks, but her abdomen is bloated. Mrs Jones tells you she does not have much of an appetite and feels full after a few bites of her food.
Learning objectivesAfter successful completion of this CPD activity, pharmacists should be able to: • Identify the types of ovarian cancer Competency standards (2016) addressed: 1.1, 1.4, 1.5, 2.2, 3.1, 3.5 |
Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.
Introduction
Ovarian cancer (OC) refers to a malignant tumour in one or both of the ovaries. It is the sixth leading cause of cancer deaths among females in Australi
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
